Haemonetics Corporation (HAE)
HAENYSEMedical/Dental Instruments
$121.34
0.0000 (0.00%) today
Pre-market, Nov 16, 4:00 PM ET
- Market cap
- $5.53bn
- P/E
- 23.8
- EPS, last 4 quarters
- $5.09
- Dividend yield
- –
- Day range
- –
- 52-week range
- $51.00 to $132.00
- Average volume
- –
- Previous close
- $121.34
Analysts
9 coveringBuy7 buy, 2 hold, 0 sell
Targets a year out average $145.56, +20.0% from here
Earnings
next estimate $1.26Next report
Dec 2025
+3.1%
Mar 2026
+0.8%
Jun 2026
+6.5%
Sep 2026
+3.9%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $338.97m | $346.35m | $339.38m | $357.76m |
| Gross profit | $202.39m | $198.21m | $202.80m | $220.91m |
| Operating income | $67.40m | -$23.02m | $57.46m | $75.12m |
| Net income | $44.74m | -$20.15m | $33.01m | $46.30m |
Last four quarters: revenue $1.38bn, margin 7.5%, free cash flow $259.84m
News
8 latest- International Markets and Haemonetics (HAE): A Deep Dive for InvestorsZacks · Nov 9, 2026
- Haemonetics Q2 Earnings Call HighlightsMarketBeat · Nov 7, 2026
- Haemonetics (HAE) Q2 2027 Earnings Call TranscriptThe Motley Fool · Nov 5, 2026
- Haemonetics Reports Q2 Fiscal 2027 Results; Raises Full-Year Revenue And Organic Growth Outlook RTTNews · Nov 5, 2026
- Haemonetics Corporation (HAE) Hits Fresh High: Is There Still Room to Run?Zacks · Nov 5, 2026
- Haemonetics Q2 27 Earnings Conference Call At 8:00 AM ET RTTNews · Nov 5, 2026
- Haemonetics Corporation Reports Second Quarter Fiscal 2027 Revenue of $357.8 millionFintel · Nov 5, 2026
- Haemonetics Raises FY27 Revenue Outlook After Q2 Revenue Growth Of 9% RTTNews · Nov 5, 2026
The company
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our Apheresis business features proprietary technologies designed to enhance safety, yield, donor satisfaction and operational efficiency for plasma and blood collectors around the world. Our MedSurg business offers Blood Management Technologies to help inform treatment decisions and optimize the management of blood products, and Interventional Technologies, including advanced vascular closure systems and sensor-guided technologies, designed to drive procedural effectiveness and elevate the patient experience.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Exchange
- NYSE
- Region
- North America
- Website
- haemonetics.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.